Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case series

Objective: Vagus nerve stimulation (VNS) is a treatment option for patients with drug-resistant seizures, but it is also associated with sleep-disordered breathing (SDB). We present four patients with VNS who underwent polysomnography (PSG) concurrently with VNS stimulation monitoring and adjustment...

Full description

Bibliographic Details
Main Authors: Daniel M. Oh, Jacklyn Johnson, Bankim Shah, Sushanth Bhat, Rolla Nuoman, Xue Ming
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Epilepsy & Behavior Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2589986419300589
id doaj-2a0477ee2aec450d8dbf53aaf71a933c
record_format Article
spelling doaj-2a0477ee2aec450d8dbf53aaf71a933c2020-11-25T02:13:23ZengElsevierEpilepsy & Behavior Reports2589-98642019-01-0112Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case seriesDaniel M. Oh0Jacklyn Johnson1Bankim Shah2Sushanth Bhat3Rolla Nuoman4Xue Ming5Rutgers New Jersey Medical School, Department of Neurology, 150 Bergen St., Newark, NJ 07103, United States of AmericaRutgers New Jersey Medical School, Department of Neurology, 150 Bergen St., Newark, NJ 07103, United States of AmericaRiverside Medical Group, Bayonne Sleep Medicine, 432 Broadway, Bayonne, NJ 07002, United States of AmericaSeton Hall University, New Jersey Neuroscience Institute, Sleep Medicine Center, 65 James St., Edison, NJ 08820, United States of AmericaRutgers New Jersey Medical School, Department of Neurology, 150 Bergen St., Newark, NJ 07103, United States of AmericaRutgers New Jersey Medical School, Department of Neurology, 150 Bergen St., Newark, NJ 07103, United States of America; Seton Hall University, New Jersey Neuroscience Institute, Sleep Medicine Center, 65 James St., Edison, NJ 08820, United States of America; Corresponding author at: Department of Neurology, Rutgers New Jersey Medical School, 90 Bergen Street, DOC 8100, Newark, NJ 07103, United States of America.Objective: Vagus nerve stimulation (VNS) is a treatment option for patients with drug-resistant seizures, but it is also associated with sleep-disordered breathing (SDB). We present four patients with VNS who underwent polysomnography (PSG) concurrently with VNS stimulation monitoring and adjustment, and positive airway pressure (PAP) treatment. We demonstrate the importance of sleep apnea screening prior to VNS placement and the dilemma of optimizing VNS settings. Background: VNS is a common adjunct therapy for refractory epilepsy. Despite its low side effect profile, complications of VNS include delayed arrhythmias, laryngopharyngeal dysfunction, obstructive sleep apnea, and tonsillar pain mimicking glossopharyngeal neuralgia. Risk of developing or exacerbating existing obstructive sleep apnea (OSA) limits the VNS settings, as there appears to be a dose dependent effect. OSA can further cause sleep fragmentation and cause hypoxia, potentially worsening seizures. Methods: Four patients with drug-resistant epilepsy with VNS underwent PSG with concurrent VNS leads to monitor correlation of SDB and VNS. AHI was calculated to quantify SDB, and it was scored as non-VNS related when the VNS was off, and VNS-induced when the onset of SDB corresponded to VNS activation. Subsequent PAP and VNS adjustment was performed to treat the SDB episodes. Results: Three out of four patients had non-VNS associated SDB, which improved with PAP treatment. All four patients had VNS-induced SDB episodes but none improved with PAP. The VNS-induced SDB events decreased in a dose dependent manner, when VNS was adjusted down and disappeared when turned off completely. Conclusion: Our case series provides further evidence of VNS-induced SDB secondary to VNS. PAP treatment alone is ineffective for VNS-induced SDB. Screening for OSA before VNS implant is crucial; further research is needed to establish optimal VNS parameters for prevention andminimization of VNS-induced SDB along with other possible treatments. Keywords: Epilepsy, Vagus nerve stimulation, Sleep apnea, Positive airway pressure, Titrationhttp://www.sciencedirect.com/science/article/pii/S2589986419300589
collection DOAJ
language English
format Article
sources DOAJ
author Daniel M. Oh
Jacklyn Johnson
Bankim Shah
Sushanth Bhat
Rolla Nuoman
Xue Ming
spellingShingle Daniel M. Oh
Jacklyn Johnson
Bankim Shah
Sushanth Bhat
Rolla Nuoman
Xue Ming
Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case series
Epilepsy & Behavior Reports
author_facet Daniel M. Oh
Jacklyn Johnson
Bankim Shah
Sushanth Bhat
Rolla Nuoman
Xue Ming
author_sort Daniel M. Oh
title Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case series
title_short Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case series
title_full Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case series
title_fullStr Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case series
title_full_unstemmed Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case series
title_sort treatment of vagus nerve stimulator-induced sleep-disordered breathing: a case series
publisher Elsevier
series Epilepsy & Behavior Reports
issn 2589-9864
publishDate 2019-01-01
description Objective: Vagus nerve stimulation (VNS) is a treatment option for patients with drug-resistant seizures, but it is also associated with sleep-disordered breathing (SDB). We present four patients with VNS who underwent polysomnography (PSG) concurrently with VNS stimulation monitoring and adjustment, and positive airway pressure (PAP) treatment. We demonstrate the importance of sleep apnea screening prior to VNS placement and the dilemma of optimizing VNS settings. Background: VNS is a common adjunct therapy for refractory epilepsy. Despite its low side effect profile, complications of VNS include delayed arrhythmias, laryngopharyngeal dysfunction, obstructive sleep apnea, and tonsillar pain mimicking glossopharyngeal neuralgia. Risk of developing or exacerbating existing obstructive sleep apnea (OSA) limits the VNS settings, as there appears to be a dose dependent effect. OSA can further cause sleep fragmentation and cause hypoxia, potentially worsening seizures. Methods: Four patients with drug-resistant epilepsy with VNS underwent PSG with concurrent VNS leads to monitor correlation of SDB and VNS. AHI was calculated to quantify SDB, and it was scored as non-VNS related when the VNS was off, and VNS-induced when the onset of SDB corresponded to VNS activation. Subsequent PAP and VNS adjustment was performed to treat the SDB episodes. Results: Three out of four patients had non-VNS associated SDB, which improved with PAP treatment. All four patients had VNS-induced SDB episodes but none improved with PAP. The VNS-induced SDB events decreased in a dose dependent manner, when VNS was adjusted down and disappeared when turned off completely. Conclusion: Our case series provides further evidence of VNS-induced SDB secondary to VNS. PAP treatment alone is ineffective for VNS-induced SDB. Screening for OSA before VNS implant is crucial; further research is needed to establish optimal VNS parameters for prevention andminimization of VNS-induced SDB along with other possible treatments. Keywords: Epilepsy, Vagus nerve stimulation, Sleep apnea, Positive airway pressure, Titration
url http://www.sciencedirect.com/science/article/pii/S2589986419300589
work_keys_str_mv AT danielmoh treatmentofvagusnervestimulatorinducedsleepdisorderedbreathingacaseseries
AT jacklynjohnson treatmentofvagusnervestimulatorinducedsleepdisorderedbreathingacaseseries
AT bankimshah treatmentofvagusnervestimulatorinducedsleepdisorderedbreathingacaseseries
AT sushanthbhat treatmentofvagusnervestimulatorinducedsleepdisorderedbreathingacaseseries
AT rollanuoman treatmentofvagusnervestimulatorinducedsleepdisorderedbreathingacaseseries
AT xueming treatmentofvagusnervestimulatorinducedsleepdisorderedbreathingacaseseries
_version_ 1724905553314971648